How can Trump's tariff hike from 0% to 200% on generic medicines affect India?

US President Trump said imported generic drugs will face 0% tariffs for two years from August 2026, followed by 100% tariffs for one year and 200% thereafter. India supplies 40% of generic medicines used in US by volume, while pharmaceutical exports to US reached $10.5 billion in 2024-25. Indian-made generic medicines are used to treat hypertension and cancer in US.